Janux Share Price

Janux Share Price

NASDAQ: JANX | Small Cap | Healthcare
$10.08
-$0.21 (-1.99%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Janux Stock Performance

Open
$10.19
Prev. Close
$10.29
Circuit Range
N/A
Day Range
$10.06 - $10.48
Year Range
$10.06 - $35.24
Volume
44,808
Average Traded
$10.23

Janux Share Price Today

As of 21 November 2026, Janux Therapeutics, Inc.'s share price is $10.08. The stock opened at $10.19, compared to its previous close of $10.29. During today's trading session, Janux Therapeutics, Inc.'s share price traded between $10.06 and $10.48, with an average price of $10.27. Over the past 52 weeks, the stock has recorded a high of $35.24 and a low of $10.06. In terms of performance, Janux Therapeutics, Inc.'s share price has declined by 30.91% over the last six months and is down 70.48% on a year-on-year basis.

Janux Share Price Chart

Line chart of the Janux price trend over the selected period. The price fell overall, ranging from 10.06 to 10.52, ending at 10.08.
$10.06$10.48
L
Show Current Price
H

Janux Stock Fundamentals & Key Indicators

Market Cap
$624.63M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.63
Revenue (TTM)
$10.00B
Return On Equity (TTM)
-10.95%
Profit Margin
-1136.30%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
32.49%

Janux Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$3.73$10.27$9.29
Net Profit-$31.95-$24.36-$21.97-$21.57
Net Profit MarginN/A-653.08%-213.92%-232.19%
Income ChangeN/A23.76%9.81%1.82%

Janux Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$8.61$8.08$10.59$10.00
Net Profit-$63.06-$58.29-$68.99-$113.63
Net Profit Margin-732.40%-721.41%-651.46%-1136.30%
Income ChangeN/A7.56%-18.36%-64.71%

Janux Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets25.6827.8531.1731.57
Current Assets975.891033.67349.24332.44
Total Assets1001.571061.52380.41364.01
Non Current Liabilities19.7521.2823.0326.76
Current Liabilities25.017.4613.0316.51
Total Liabilities44.7438.7436.0643.27
Shareholders' Equity956.821022.78344.35320.74

Janux Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-82.24-43.81-50.58-42.92
Investing-300.98-258.02-41.1958.27
Financing4.95713.2459.550.5

About Janux

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Janux Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$17.64
$10.09
-42.32%
Oct 2026
$17.18
$17.48
+0.98%
Sep 2026
$18.23
$17.32
-7.73%
Aug 2026
$15.23
$18.77
+23.94%
Jul 2026
$15.36
$15.14
-1.30%
Jun 2026
$14.50
$15.34
+5.14%
May 2026
$14.20
$14.59
+1.60%
Apr 2026
$14.11
$14.36
+3.38%
Mar 2026
$13.40
$13.89
+1.91%
Feb 2026
$13.61
$13.63
-0.44%
Jan 2026
$13.75
$13.69
-0.80%
Dec 2025
$33.70
$13.80
-59.59%

Janux Share Price FAQs